您的位置: 首页 > 农业专利 > 详情页

RECEPTEURS SOLUBLES BR43x2 ET PROCEDES D'UTILISATION
专利权人:
ZYMOGENETICS; INC.
发明人:
申请号:
EP00902354.0
公开号:
EP1141274B2
申请日:
2000.01.07
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
The invention provides uses of polypeptides of soluble BR43x2 class receptors, and sequences substantially homologous thereto or orthologs thereof, as well as antibodies that bind to BR43x2 class soluble receptors in the manufacture of medicaments for inhibiting ztnf4 activity. The uses of the invention also extend to manufacture of medicaments for treating autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, multiple sclerosis and rheumatoid arthritis, amongst others. <;IMAGE>;The invention provides uses of polypeptides of soluble BR43x2 class receptors, and sequences substantially homologous thereto or orthologs thereof, as well as antibodies that bind to BR43x2 class soluble receptors in the manufacture of medicaments for inhibiting ztnf4 activity. The uses of the invention also extend to manufacture of medicaments for treating autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, multiple sclerosis and rheumatoid arthritis, amongst others. <;IMAGE>;
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充